key: cord-0892915-z7oh7xy9
authors: Imamura, Teruhiko
title: Therapeutic Strategy for Patients with Coronavirus Disease 2019 during Left Ventricular Assist Device Supports
date: 2020-05-01
journal: J Card Fail
DOI: 10.1016/j.cardfail.2020.04.014
sha: 050086847f6644a3134cb4bcf758d0eed92b8401
doc_id: 892915
cord_uid: z7oh7xy9

nan

Patients with cardiovascular comorbidities, including advanced heart failure, are at higher risk of mortality and morbidity associating with coronavirus disease 2019 (COVID-19). In that context, I raise several questions about report of Singh and colleagues, presenting a patient who suffered from COVID-19 during durable left ventricular assist device (LVAD) support. 1 

None Reference:

Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support

Noninvasive Assessment of Hemodynamics in Left Ventricular Assist Device Patients: Echocardiographic Accuracy and Clinical Outcome Implications

COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support